% Expired Patents = 33.3

CIPO Patents = 1

EPO Patents = 1

Forward Citations = 11

Loading Chart...

10 inventors (with patents filed for the assignee):

Seong-Wook Lee (1 out of 22 patents)

Jong-Hoon Lim (1 out of 3 patents)

Joungmin Han (1 out of 1 patent)

4. Chankyu Jeoung (1 out of 1 patent)

5. Sehhyon Song (1 out of 1 patent)

6. Se-il Sohn (1 out of 1 patent)

7. Kyung-Sook Shin (1 out of 1 patent)

8. Young Woo Lee (1 out of 44 patents)

9. Bu Hyun Baik (1 out of 1 patent)

10. Yong Bok Lee (1 out of 1 patent)

11. Young-Joo Lee (14 patents)

12. Chang-Ho Lee (0 patent)

13. Chang-Ho Lee (1 patent)

3 patents: Sort by Forward Citations

1. 9006294 - Oral pharmaceutical formulation of pelubiprofen with improved dissolution rate and stability (2015-04-14),

2. 8008272 - Nuclease-resistant RNA aptamer inhibiting replication of hepatitis C virus replicon (2011-08-30),

3. 5700832 - Antianemic agent containing iron and difructose (1997-12-23),

Company Badge

USPTO Data Jan 1 1976 - Oct 20 2026

3 Patents

#969 in Seoul

#2,797 in South Korea

Seoul, South Korea

Daewon Pharm., Co., Ltd.

Forward Citations = 11

10 inventors:

Seong-Wook Lee (1 out of 22 patents)

Jong-Hoon Lim (1 out of 3 patents)

Joungmin Han (1 out of 1 patent)

4. Chankyu Jeoung (1 out of 1 patent)

5. Sehhyon Song (1 out of 1 patent)

IDiyas Innovation Intelligence. (2026). Company Patent Portfolio: Daewon Pharm., Co., Ltd.. Retrieved from https://idiyas.com/company/daewon-pharm-company

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (CIPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]

1 patent (EPO):

Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]